Spots Global Cancer Trial Database for time to progression
Every month we try and update this database with for time to progression cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Maintenance Treatment for Ovarian Carcinoma in Remission by an Antiangiogenic Treatment Strategy | NCT01175772 | Ovarian Carcino... | Cytophosphan, C... | 20 Years - 80 Years | HaEmek Medical Center, Israel | |
| Maintenance Treatment for Ovarian Carcinoma in Remission by an Antiangiogenic Treatment Strategy | NCT01175772 | Ovarian Carcino... | Cytophosphan, C... | 20 Years - 80 Years | HaEmek Medical Center, Israel | |
| Mithramycin for Children and Adults With Solid Tumors or Ewing Sarcoma | NCT01610570 | Ewing Sarcoma Sarcoma | Mithramycin | 1 Year - | National Institutes of Health Clinical Center (CC) | |
| Transcatheter Arterial Chemoembolization Combined With Sorafenib for Unresectable Hepatocellular Carcinoma | NCT01833299 | Hepatocellular ... Face Cancer | TACE-Sorafenib ... TACE | 18 Years - 75 Years | Sun Yat-sen University | |
| Combination of Capecitabine and Oxaliplatin in Patients With Relapsed or Refractory Gastric Cancer | NCT00568529 | Gastric Cancer | Capecitabine an... | 18 Years - 70 Years | Fudan University | |
| Pazopanib Versus Temsirolimus in Poor-Risk Clear-Cell Renal Cell Carcinoma (RCC) | NCT01392183 | Kidney Cancer | Pazopanib Temsirolimus Quality of Life... Benadryl | 18 Years - | M.D. Anderson Cancer Center | |
| Sorafenib as a Second Line Treatment in Patients With Advanced or Metastatic Gastric Cancer | NCT00595985 | Gastric Cancer | sorafenib | 18 Years - 70 Years | Fudan University | |
| A Randomized Study to Determine the Efficacy of a Taxane and Bevacizumab With or Without Capecitabine as First Line Chemotherapy in Patients With Metastatic Breast Cancer | NCT01200212 | Breast Cancer | Taxane, Avastin Taxane, Avastin... | 18 Years - | German Breast Group | |
| Continuous Infusion of FU Combined With Epirubicin and Oxaliplatin in Patients With A/MGC | NCT00767377 | Gastric Cancer | EOF5 | 18 Years - 75 Years | Fudan University | |
| Combination of Capecitabine and Oxaliplatin in Patients With Relapsed or Refractory Gastric Cancer | NCT00568529 | Gastric Cancer | Capecitabine an... | 18 Years - 70 Years | Fudan University | |
| Study of Cetuximab to Treat Gastric Cancer | NCT00699881 | Gastric Cancer | cetuximab | 18 Years - 70 Years | Fudan University | |
| Pazopanib Versus Temsirolimus in Poor-Risk Clear-Cell Renal Cell Carcinoma (RCC) | NCT01392183 | Kidney Cancer | Pazopanib Temsirolimus Quality of Life... Benadryl | 18 Years - | M.D. Anderson Cancer Center | |
| Mithramycin for Children and Adults With Solid Tumors or Ewing Sarcoma | NCT01610570 | Ewing Sarcoma Sarcoma | Mithramycin | 1 Year - | National Institutes of Health Clinical Center (CC) | |
| Non -Interventional Study-Palliative Therapy of Multiple Myeloma With a Combination of Lenalidomide and Dexamethasone | NCT00911105 | Multiple Myelom... | 18 Years - | iOMEDICO AG | ||
| A Study to Evaluate Lenalidomide Combined With Dexamethasone in Relapsed or Refractory Diffuse Large B-Cell Lymphoma | NCT00474188 | Diffuse Large B... | CC-5013 (lenali... dexamethasone | 18 Years - | Celgene | |
| Study of Gefitinib Compared With Pemetrexed/Cisplatin in Advanced Non-Small Cell Lung Cancer Patients | NCT01192243 | Toxicity Non-small Cell ... | Gefitinib Pemetrexed Cisplatin or ca... | 18 Years - 70 Years | Fudan University | |
| Epirubicin Cisplatin and Fluorouracil (FU) Combined With Endostar in Patients With Advanced or Metastatic Gastric Cancer | NCT00595972 | Gastric Cancer | ECF-endostar | 18 Years - 70 Years | Fudan University | |
| Gemcitabine and Cetuximab in Patients With Advanced or Metastatic Biliary Tract Cancer: A Multicenter Phase II Study | NCT00747097 | Time to Progres... | gemcitabine + c... | 18 Years - | Cliniques universitaires Saint-Luc- Université Catholique de Louvain | |
| Study of Gefitinib Compared With Pemetrexed/Cisplatin in Advanced Non-Small Cell Lung Cancer Patients | NCT01192243 | Toxicity Non-small Cell ... | Gefitinib Pemetrexed Cisplatin or ca... | 18 Years - 70 Years | Fudan University | |
| Mithramycin for Children and Adults With Solid Tumors or Ewing Sarcoma | NCT01610570 | Ewing Sarcoma Sarcoma | Mithramycin | 1 Year - | National Institutes of Health Clinical Center (CC) | |
| Transcatheter Arterial Chemoembolization Combined With Sorafenib for Unresectable Hepatocellular Carcinoma | NCT01833299 | Hepatocellular ... Face Cancer | TACE-Sorafenib ... TACE | 18 Years - 75 Years | Sun Yat-sen University | |
| Study of Cetuximab to Treat Gastric Cancer | NCT00699881 | Gastric Cancer | cetuximab | 18 Years - 70 Years | Fudan University | |
| Study of Cetuximab to Treat Gastric Cancer | NCT00699881 | Gastric Cancer | cetuximab | 18 Years - 70 Years | Fudan University |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
